Pasithea Therapeutics Corp Share Price Today: Live Updates & Key Insights
Pasithea Therapeutics Corp share price today is $0.797, up 1.91%. The stock opened at $0.766 against the previous close of $0.7821, with an intraday high of $0.80425 and low of $0.7629.
Pasithea Therapeutics Corp Share Price Chart
Pasithea Therapeutics Corp
Pasithea Therapeutics Corp Share Price Performance
Pasithea Therapeutics Corp Institutional Holdings
Pasithea Therapeutics Corp Market Status
Pasithea Therapeutics Corp Fundamentals
Market Cap 25.09 M
PB Ratio 1.5077
PE Ratio 0.0
Enterprise Value 6.43 M
Total Assets 16.06 M
Volume 205108
Pasithea Therapeutics Corp Company Financials
About Pasithea Therapeutics Corp & investment objective
Company Information Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Organisation Biotechnology
Employees 4
Industry Biotechnology
CEO Dr. Tiago Reis Marques M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Pasithea Therapeutics Corp FAQs
What is the share price of Pasithea Therapeutics Corp today?
The current share price of Pasithea Therapeutics Corp is $0.797.
Can I buy Pasithea Therapeutics Corp shares in India?
Yes, Indian investors can buy Pasithea Therapeutics Corp shares by opening an international trading and demat account with Motilal Oswal.
How to buy Pasithea Therapeutics Corp shares in India?
You can easily invest in Pasithea Therapeutics Corp shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Pasithea Therapeutics Corp shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Pasithea Therapeutics Corp.
Can I buy fractional shares of Pasithea Therapeutics Corp?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Pasithea Therapeutics Corp?
Pasithea Therapeutics Corp has a market cap of $25.09 M.
In which sector does Pasithea Therapeutics Corp belong?
Pasithea Therapeutics Corp operates in the Biotechnology sector.
What documents are required to invest in Pasithea Therapeutics Corp stocks?
To invest, you typically need:
What is the PE and PB ratio of Pasithea Therapeutics Corp?
The PE ratio of Pasithea Therapeutics Corp is N/A and the PB ratio is 1.51.